This study was aimed at evaluating the hypolipidemic effects of ethanolic extract of Azima tetracantha Leaves against liver toxicity induced by carbon tetrachloride (CCl 4 ) in male albino Wistar rats and to compare the same with the reference drug silymarin. Six groups of rats with six rats in each group were used as the experimental subject. Animals were allocated into a control group and liver toxicity control group. The remaining four groups received in addition to CCl 4 , silymarin (20 mg/kg/d) as a reference treatment and Azima tetracantha (100, 200 and 400mg/kg/d). Once the experiment period was completed, the biomarkers of lipid pro ile, including total cholesterol, serum triglycerides, high-density lipoprotein (HDL) and low-density lipoprotein (LDL)] were evaluated. Azima tetracantha signi icantly decreased the serum lipid pro ile markers cholesterol, triglycerides, phospholipids, fatty acids, VLDL, LDL, and increased HDL. Azima tetracantha could be a promising protective agent against cholesterol through the improvement of liver function, modulation of CCl 4 by-products formation and thus has hypolipidemic potentials.
INTRODUCTION
Lipids, like phosphoglycerolipids, sphingolipids, and neutral lipids, are natural components of living membranes and lipoproteins that are circulating in the blood. These lipids have an integral role in multiple biological processes, including apoptosis, proliferation, in lammation, and differentiation (Mene et al., 1989; Ridgway, 2013) . Any alterations in the highly controlled lipid homeostasis can cause hepatic diseases and injury. To understand the pathophysiology of such diseases, the characterization of the alteration of lipids must be of key focus. One of the key functions attributed to the liver is invariably the synthesis of lipoproteins. The close correlation between the composition of lipids in the liver and that in the plasma has been unraveled in a recent study (Kotronen et al., 2010) . Hence in understanding the hepatic pathophysiology, plasma lipid pro iling is of immense signi icance and is being in practice. It has been already used in identifying biomarkers for hepatocellular carcinoma (Patterson et al., 2011; Chen et al., 2013) liver phospholipidosis (Saito et al., 2014) , and non-alcoholic fatty liver disease (Puri et al., 2009 ).
Carbon tetrachloride (CCl 4 ) is one of the best agents in inducing liver injury and can give a platform for its pathophysiological studies. (Boll et al., 2001) . It has been notorious for causing harm to the liver, central nervous system, lungs, and adrenals, both in human and experimental animals (McGregor and Lang, 1996) . CCl 4 undergoes biological transformation by microsomal P450 of the liver. This results in the production of the liver toxifying metabolite called trichloromethyl radical (CCl 3 ). This is later converted to a peroxy radicals in the presence of oxygen. These products might interact with the lipids of living membranes resulting in its peroxidation (Muriel, 1997) . An imbalance between the production and morti ication of lipids is caused by CCl 4 (Boll et al., 2001) . In view of this, this study was carried out to analyze the effect of Azima tetracantha ethanolic leaves extract administration, on the lipid pro ile in carbon tetrachloride-induced hyperlipidemic rats.
MATERIALS AND METHODS

Animals
Wistar strain albino rats (male) of, approximately 3-4 months (weighing around 140-160g) were the experimental subjects. They were bought from Sri Venkateswara Enterprises, Bangaluru, India in good health conditions. They were accommodated in plastic cages in which rice husk was used as bedding. The cages were well aerated and were retained under standard experimental conditions (Twelve hours light and dark cycle, Temperature 27±2ºC) throughout during the experimental phases. They were nourished with standard pellet diet obtained from Gold Mohur, Mumbai, India and water ad libitum. The subjects were attuned for a period of 1 week before the experimental use. The experiment strictly followed the recommendations of the Ethical Committee (Ethical No: SAC/IAEC/BC/2016/Ph.D-005), which stands for supervising and controlling the experiments done on Animals (CPCSEA New Delhi, India).
Chemicals
Carbon tetrachloride (CCl 4 ), thiobarbituric acid (TBA), Nitro blue tetrazolium (NBT), ethylenediaminetetraacetic acid (EDTA), trichloroacetic acid (TCA), 1-chloro-2,4-dinitrobenzene (CDNB), 5,5'-dithio-bis (2-nitrobenzoic acid), glutathione (oxidized). Glutathione (reduced), Carbon tetrachloride and L-ascorbic acid were obtained from Sigma Chemical Company (St. Louis, MO, USA). All other chemicals were taken from Glaxo Laboratories situated in Mumbai, India, and Sisco Research Laboratories, Mumbai, India and were of analytical grade.
Plant Material
Garden fresh leaves of A. tetracantha were gathered from Melur, Thiruchirappalli District, Tamil Nadu, South India in January 2015. The specimen was authenticated and identi ied by Dr S. John Britto, Director, 'The Rabinat Herbarium and center for molecular systematics', St. Joseph's college TrichyTamil Nadu. India. Its Specimen voucher (EP001) is stored at the Rabinat Herbarium, St. Josephs College, Tiruchirappalli, Tamil Nadu, India.
Preparation of Plant Extract
The leaves of Azima tetracantha were thoroughly washed, cut and later desiccated in a hot-air oven at 37
• C. The dried and desiccated material was ground to obtain ine dust, which was later used to extract the phytoconstituents. Two hundred and ifty grams (250g) of the powdered material was then extracted with hexane, chloroform, and ethanol in "Soxhlet Apparatus" for around 48 hours. Resultant was a semi-solid material; once alcohol was eliminated under minimized pressure. It was later stored in the refrigerator. The extracted material had polar as well as non-polar phytoconstituents in it. For our experiments, 100, 200 and 400mg/kg bodyweight of Azima tetracantha ethanolic leaves extract was used. Selection of the effectual dose was based on the results of dose-dependent experiments performed with the extract which was conducted in our laboratory.
Experimental Design
After recording the bodyweight of the animals, they were divided into 6 groups, each comprising 6 animals listed as follows.
Group I -Normal Rats
Group II -Negative control -Animals were administrated orally with CCl 4 (0.5 ml/150g of bw-v/v in olive oil) on 1 st , 8 th and 16 th day. 
Collection of Various Samples
After completing the experimental duration, animals were killed by decapitation. Plasma was separated, and biochemical parameters were analyzed.
Biochemical parameters
Cholesterol in the serum and tissue was estimated by the method of Parekh and Jung (1970) . Triglycerides in the serum and tissue were estimated by the method of Foster and Dunn, (1973), Phospholipids was estimated by the Bartlette method (1959). Nonesteri ied fatty acids estimation was by the Falholt et al. method (1973) . Serum HDL was estimated by Friedewald et al. method, (1972) .
Statistical Analysis:
The mean ± SD for six rats in each group were expressed as numerical values. One way analysis of variance (ANOVA) was employed for determining statistically signi icant differences between mean values. It was later followed by individual comparison that was obtained by Duncan's Multiple Range Test (DMRT) using the SPSS software for Windows Version 20.0 (IBM Corp. Armonk, New York, NY, USA). A value of p < 0.05 was contemplated to indicate a signi icant difference between groups.
RESULTS AND DISCUSSION
Effect of Azima tetracantha leaves extract lipid pro ile markers
CCl 4 showed a marked increase in serum total cholesterol, free fatty acids, phospholipids, LDL, and TGS levels, while a noticeable decrease in serum level of HDL compared to normal control groups. Treatment of rats with Azima tetracantha ethanolic extract of leaves or silymarin signi icantly reduced serum total cholesterol, phospholipids, free fatty acids, LDL, and TGS levels whereas the serum level of HDL was signi icantly increased as compared to the control. Azima tetracantha leaves extract restored cholesterol to normal levels, like silymarin restoring TGS to normal levels (Table 1) Results of this investigation disclosed that CCl 4 increased serum levels of triglycerides, cholesterol, and LDL, while it produced a remarkable decrease in serum levels of HDL. Our observations add further evidence for the previous reports of (Andritoiu et al., 2014) , that CCl 4 aggravates lipid pro ile by cellular oxidative stress. Mediated by the free radicals derived from CCL 4, hepatic lesions are produced. The more the oxidative stress is intensi ied, the more enhanced the in luence of non-essential fatty acids to aggravate the serum levels of cholesterol and triglyceride.
CCl 4 induced fatty liver development involves predominant cellular mechanisms like lipid peroxidation and radical formation (Tribble et al., 1987) . Accumulation of lipids in large volumes in the liver is symptomatic underlying a pathological condition and in chronic situations; these cells undergo ibrosis that headway to cirrhosis and thus resulting in impeded liver function (Murray et al., 1993) . CCl 4 hastens fatty acids and triglycerides synthesis from acetate. CCl 4 could cause the movement of acetate into the liver cell, which results in elevated availability of the substrate (acetate) for its conversion to the above lipids. During CCl 4 toxicity, cholesterol synthesis is also found aggravated (Boll et al., 2001 ).
The hydrolysis of triglycerides and β-oxidation of fatty acids is found to ameliorating upon CCl 4 introduction. This intensi ies fatty acids availability for esteri ication (Lieber, 2000) . Moreover, it is reported that CCl 4 toxicity results in the accumulation of fat in the liver and kidney, which has been due to the translocation of the same from the peripheral adipose tissue. (Devarshi et al., 1986) . Apolipoproteins synthesis is found to be inhibited by CCl 4 [16] henceforth resulting in the reduction of the synthesis of lipoproteins. Reports also suggest that bile acids secretion is also found to be decreased by CCl 4 (Honma and Suda, 1997) .
Being a vital component of biomembranes, the phospholipids are more prone to CCl 4 -induced lipid peroxidation compared to other lipid types (Morrow et al., 1992) . An increase in phospholipase activity may probably cause a concomitant decrease of phospholipids concentration in liver and kidney (Lamb et al., 1988) . Extensive conversion of phospholipids into triglycerides is normal during lipoprotein metabolism (WIGGINS and GIBBONS, 1996) . Triglyceride export associated with lipoprotein, as inhibited by CCl 4 becomes a reason for releasing of more phospholipids from these tissues.
Results of the current study disclosed that Azima tetracantha leaves extract signi icantly reduced serum levels of lipid biomarkers such as triglycerides, total cholesterol, and LDL, while it produced a noticeable elevation in serum level of HDL, which probably might be assigned to the role played by lavonoids through its antioxidant mechanism. By counterpoising the polyunsaturated fatty acid radicals, by obstructing the chain reactions and by suppressing the impact of non-essential fatty acids, lavonoids are found to be acting as inhibitors of lipid peroxidation which, probably has decreased the serum and tissue levels of cholesterol and triglycerides. Similar results were also shown by (Wang et al., 2011) who stated that hesperidin effectively reduced the steatosis of fatty liver, liver 
